On Aug. 8, I wrote a Spotlight column entitled “Project 2025 will gut worker protections.” In the coming months, I will ...

The oft-cited silver lining in this market has been the ... The vicissitudes of the market often depress public biotech prices such that even a hard-to-refuse 100% price premium does not generate ...

The silver lining is that certain states are investing in innovation ... but I think the campaign was pretty light on ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

But one of the most powerful aspiring entrants, Novo Nordisk, may not be as intimidating for the biotech as it once was. Novo's molecule semaglutide (commonly known by the trade names Ozempic and ...

If I had to buy one share of any biotech with no price restriction, I'd naturally gravitate toward the most successful companies in the industry. However, the exercise becomes more complicated if ...

United Therapeutics Corp. operates as a biotechnology company ... Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Real-time index price for PHLX Gold/Silver Index (XAU), along with buy or sell indicators, analysis, charts, historical ...

The analysts might have been a bit too bullish on Vir Biotechnology, Inc. ( NASDAQ:VIR ), given that the company ...

The biotech is reviewing the data before deciding ... with IPOs north of $100M each The available evidence is light on silver linings. In a note to investors, William Blair analysts said Alto ...